QuickView for RNA polymerase II activity (biogroup)

1. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
4. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
5. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens

There were no matches for RNA polymerase II activity

1. Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autolog…
2. Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
3. Ladarixin With Sotorasib in Advanced NSCLC - Phase II
4. Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
5. Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer